Scenarios that move CGON

CG Oncology, Inc. - Common stock

Scenarios that move CGON: 1 analysis, 0 positive, 1 negative.

1. 2026-10-15 · FDA expands ImmunityBio's Anktiva label for bladder cancer — ▼ · impact -51 · confidence medium · horizon immediate

All scenarios · Run a scenario · Pricing